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THE OVERALL GROWTH rate of tumor cell populations, like that of any other population, depends on cell proliferation, cell migration, and cell death. While the kinetics of tumor growth have been extensively studied in recent years (1-5), many aspects of cell migration remain speculative and obscure. Even less is known about tumor cell death in vivo. The lack of precise information on these questions is caused primarily by technical difficulties, since most of the procedures currently used for measuring cell death and cell migration 358-747--69----3 yield reliable results only under very specialized conditions. For example, the equations presented by Quastler and Sherman (6) for estimating the average life expectancy of cells in the intestinal epithelium apply only to systems that are in a steady state. While the rate of cell death within a proliferating tumor population can be calculated if the total cell number, the generation time, and the rate of cell migration are known, accurate measurements of this nature are very complicated.
A direct measure of metastatic distribution and death of tumor cells should be possible by appropriately labeling tumor cells with a radioactive marker and following their fate and distribution after inoculation into new hosts. The label should be located intracellularly and should not leak out of the cells while they are alive. It also should not damage the cells and should be rapidly excreted from the host when the labeled cells die. Attempts to study the fate of tumor cells by labeling with 32p (7) or 51Cr (8) (9) (10) have been only partially successful, since a fraction of either isotope can exchange out of the living cell and because both isotopes are largely reutilized by surviving tumor cells or normal host cells after death and breakdown of labeled cells. This produces a progressively larger error when the fate and distribution of tumor cells are studied over extended periods (11) .
Studies on normal tissues (12) suggested that the radioactive DNA precursor 125I-iododeoxyuridine (l25IUDR) might be more suitable for measuring death and migration of tumor cells. 125IUDR injected intraperitoneally into mice bearing L1210 lymphoid leukemia is incorporated very efficiently into DNA of the peritoneal tumor cells, especially during the early phases of tumor development (13) . After incorporation into the DNA, radioiodine (1 25 1) remains bound within the cells until they die (12, 14) . When a labeled cell dies, rapid deiodination and excretion of the DNA breakdown products limit the reutilization of radioactivity by other cells (12) . Since large amounts 0[1 25 1 activity can be incorporated into the DNA of L1210 cells, it should be feasible to inoculate these cells into new, nonradioactive mice and to monitor the fate of the labeled cells and their progeny within the new hosts. Since 125 1 is a -y-ray-emitting isotope that can be detected in whole animals, it is possible to detect cell death by monitoring the loss of 125 1 activity from individual mice throughout the development of the tumor without killing the test animals. In addition, the 125 1 activity of various organs can be measured at different time intervals after inoculation of 125IUDR-labeled L12l0 cells, permitting a quantitative study of the metastasis of Ll210 cells. The following report describes this technique, indicates its limitations, and provides evidence for substantial rates of death and migration of some transplantable tumors. These results must be considered in any overall evaluation of tumor growth and may provide new avenues for tumor therapy.
MATERIALS AND METHODS
L1210 mouse lymphoid-leukemia cells were grown in the peritoneal cavity of 10-to l2-weekold (C3H X DBA/2J)F 1 (C3D2F 1J)4 female mice by weekly passage of 10 6 cells. Four days after inoculation, the Ll210 cells were labeled by two intraperitoneal injections of 0.5-25 uc 125IUDR per mouse. Except for a few experiments, the usual labeling dose was 2.5 p.c 125IUDR per injection per mouse. The two injections were given 6 hours apart to assure complete labeling of the tumor population. Two days after the administration of 125IUDR, the mice were killed in a chloroform chamber and the leukemia cells were harvested under sterile conditions by repeatedly flushing the peritoneal cavity with Earle's balanced salt solution.
Tumor cells from 5-10 mice were pooled and twice washed by gentle centrifugation at 400 rpm for 10 minutes to remove associated radioiodide. After each centrifugation, the tumor cells were resuspended in fresh Earle's balanced salt solution and filtered through a funnel lined with fine gauze to eliminate cell clumps from the suspension. During these procedures the cell suspension was kept continuously at 4°C. The final sample contained approximately 10% of the radioactivity originally injected into the mice and over 90% of this 125 1 activity was associated with the DNA of the leukemia cells (13) .
To study the death and anatomical distribution of 125IUDR-Iabeled cells, 5 to 10 X 10 6 Ll210 cells were inoculated intraperitoneally (ip), in-tramuscularly (im, both hind legs), subcutaneously (sc, under the skin of the back), or intravenously (iv, tail vein) into C3D2F I1 mice. To determine the excretion time of 125I-labeled breakdown products, a control group of mice received an inoculum of labeled cells that had been killed by repeated freezing and thawing or by heating in an 80°C water bath for 15 minutes. In some experiments, groups of mice were inoculated with free 125 1 or with a suspension of radioactive nucleoprotein, which had been extracted from dead 125IUDR_ labeled tumor cells with aiM sodium chloride solution, clarified by centrifugation, and precipitated by dilution to isotonic salt concentration (16, 17) .
One or two days before the mice were injected with 125IUDR-labeled tumor cells, their drinking water was supplemented with 0.1% sodium iodide to depress subsequent accumulation of 125 1 in the thyroid. Immediately after tumor inoculation, and at daily intervals thereafter, the whole-body 125 1 radioactivity of the mice was monitored by counting individual live mice in a well-type crystal scintillator (well diameter 35 mm). The mice were placed in plastic holders, which permitted efficient detection of the 30 kev X rays of 125I. Care had to be taken to avoid contamination of the well by urination. To study the anatomical distribution of radioactivity, some of the mice were killed in a chloroform chamber 4 days after inoculation of the 125IUDR-prelabeled cells. The leukemia cells in the peritoneal cavity were removed by repeated washings with saline. The 125 1 activity in the DNA of the tumor cells, the liver, spleen, intestine, skin, and the rest of the body was measured after homogenizing all organs (except the skin), followed by precipitation of the DNA with 10% trichloroacetic acid to remove 125 1 activity not incorporated into DNA (12) .
Similar experiments were undertaken with Ehrlich ascites cells. The mouse strain used in these studies was SJL/J. Five p.c of 125IUDR was injected ip on day 4 and again on day 5 after inoculation of 10 6 Ehrlich ascites cells. The animals were killed on day 8 when enough tumor cells for transplantation had accumulated. Otherwise, the experiments with Ehrlich ascites tumor cells were carried out exactly as described for LI210 cells. 
RESULTS

Loss of 125 1 Activity From Mice Inoculated With 125lUDR-Labeled Tumor Cells
Text- figure 1 shows the loss of 125 1 activity from groups of mice inoculated ip with 125IUDR_ labeled Ll210 cells, with radioactive nucleoprotein, or with radioiodide. The slope of the curve for living Ll210 cells indicates that a significant fraction of the 125 1 activity was lost from the leukemic mice each day. The excretion rate in this particular experiment was about 15% per day. In other experiments it was as low as 12% or as high as 18%. During the later phases of tumor development, especially in the last 2 days before the animals died, the rate of 125 1 excretion seemed to level off. In early experiments, when cell suspensions were kept at 37°C and centrifuged 3 times at 1000 rpm, we frequently observed a rapid and variable loss of radioactivity the first 24 hours after inoculation. This drop was due to the damage associated with the original preparation technique. The subsequent rate of 125 1 excretion in such experiments, however, was comparable to that observed in later experiments with lower ini tial loss rates. When heat-or cold-treated 125IUDR-labeled Ll210 cells were implanted into the peritoneal cavity of mice, more than 60% of the radioactivity was lost each day the first 2 or 3 days after inocula-The loss of 125 1 from SJL/J mice inoculated ip with living 1251UDR-labeled Ehrlich ascites cells (text- fig. 4 ) was slightly higher than the loss 0[1 25 1 from mice bearing labeled Ll210 cells in the peritoneal cavity. Whether the higher rate of 125 1 loss was due to radiation damage from the larger labeling dose used in this experiment was not determined. 125 1 excretion again seemed to slow down shortly before the death of the mice. When heat-killed 1251-labeled Ehrlich ascites cells were injected ip, the rate of 125 1 loss appeared somewhat slower than in the case of dead labeled Ll210 cells. However, the variation in 125 1 excretion between individual mice was higher in the experiments with labeled Ehrlich ascites cells than in experiments with Ll210 cells. 
DAYS AFTER TUMOR INOCULATION
considerably faster, but not so rapid as the rate of excretion from iv inoculated mice. The rate of 125 1 excretion from mice inoculated im with dead labeled Ll210 cells (data not shown) was very similar to the rate of 125 1 loss from mice receiving dead tumor cells ip. After sc implantation, no significant differences between living and dead inocula could be observed. No data were obtained on iv inoculated dead cells, since recipient mice were quickly killed by pulmonary embolism. 
tion (text- fig. 1 ). However, the rate ofl 251 excretion decreased continuously throughout the experiment. None of the mice inoculated with heat-treated LI210 cells ever died of leukemia. 125 1 excretion from mice injected with radioactive nucleoprotein closely followed the pattern obtained with dead tumor cells. Free 125 1, however, was much more rapidly excreted (text- fig. I ). Text- figure 2 shows the loss of 125 1 activity from C3D2Fd mice following ip inoculation of Ll210 cells labeled with 1, 2, 5, 10, or 50 uc 1251UDR. Labeling doses of up to 5 uc 1251UDR per mouse did not affect the rate of 125 1 excretion, while higher doses accelerated the loss of radioactivity from the usual 15% per day to 25-30%. On day 6, when the I, 2, and 5 p,c groups still retained 60% of the inoculated 125 1 activity, the 10 iu: group retained only 41%, and the 50 p,c group no more than 24%. The rate of 125 1 excretion from heat-killed Ll210 cells did not vary with the different labeling doses and was exactly the same as shown in text-figure 1. Text- figure 3 shows the loss of 125 1 activity from C3D2FIJ mice inoculated ip, im, sc, or iv with living labeled LI210 cells. Excretion of 125 1 was slowest from ip inoculated mice. Following sc and im implantation, the loss of 125 1 activity was Radioactive excretion as a measure of cell death.-Our most surprising observation was the rapid rate of excretion of radioactivity from mice bearing living 125IUDR-labeled tumor cells. This loss of 125 1 activity can be used as an index of naturally occurring tumor cell death if: 1) the 125 1 in the inoculum is associated exclusively with the DNA of the tumor cells and is not released from the DNA of labeled cells while they are alive; 2) 1251UDR does not damage or kill the labeled tumor cells; and 3) 125 1 is rapidly excreted following the death of labeled cells.
DISCUSSION
and spleens of iv inoculated mice. Immediately after iv inoculation, most of the radioactivity could be recovered from the lungs (data not shown). However, activity rapidly left the lungs, and on day 4 up to 30% of the radioactivity retained in the whole body was found in the liver, whereas only 2% remained in the lungs. By way of contrast, in the case of ip, im, and sc inoculated mice only 3-5% of the retained radioactivity was in the liver when the animals were killed (table 1) . After inoculation of dead labeled tumor cells, the skin and the intestine retained almost as much radioactivity as with living inocula. Intestinal radioactivity results from reutilization of IUDR released from dead cells, and one day after inoculating dead cells it was approximately twice as great as that reported on day 4, since during this interval much of the labeled DNA in intestine should turn over. Conversely, the label from living cells progressively accumulates in the intestine as these cells die and was higher on day 4 than on day 1. 125 1 retention in other organs, however, was greatly reduced, and almost all of the radioactivity had disappeared from the peritoneal cavity on day 4 after ip inoculation of dead labeled tumor cells.
The anatomical distribution of 125IUDR-labeled Ehrlich ascites cells (table 1, last columns) showed little evidence of cell migration. More than 75% of the retained 125 1 activity remained within the peritoneal cavity, and the small amounts present in other parts of the body did not significantly exceed that attributable to reutilization as indicated by the distribution after the inoculation of dead cells. While within a given experiment the anatomical distribution of 125 1 activity was generally much more variable than the total body retention, basically, the organ distribution of radioactivity was dependent on the route of administration of the labeled Ll210 cells (table 1) . Four days after ip implantation, 50-60% of the retained radioactivity still remained with the cells growing within the peritoneal cavity. When labeled Ll210 cells were inoculated im, sc, or iv, only trace amounts of radioactivity were found within the peritoneal cavity (table 1). The relatively large amount 0[1 25 1 activity present in the "rest of the body" 4 days after im implantation of L 1210 cells was due to the high retention of radioactivity in the legs ofthe mice, where the labeled cells had been injected. This amounted to 9% of the inoculated radioactivity or almost half of the retained activity. In a similar manner, the cutaneous injection site also accounted for the high 125 1 content of the skin of sc inoculated mice. Almost all of this radioactivity was concentrated in a tiny nodule of Ll210 cells growing at the site of implantation. When this nodule was cut out, the remaining radioactivity of the skin was down to 2-2.5% of the inoculated dose, which is characteristic of the skin for all other routes at cell inoculation. The most interesting finding, however, was the high concentration of 125 1 in the livers VOL. 43, NO.4, OCTOBER 1969 Since earlier studies showed that iododeoxyuridine incorporated into the DNA of nonmalignant mouse cells did not leave these cells until they died (12, 14) , and since 1UDR was incorporated into the DNA of tumor cells in an analogous fashion during DNA synthesis, it appears unlikely that 125 1 is released from the DNA of living tumor cells. If DNA turnover (18) or deiodination of tumor cell DNA were responsible for the loss of radioactivity we observed, then equal amounts of 125 1 activity should be lost from living tumor cells in all parts of the body. However, L1210 cells inoculated iv lost radioactivity three times as fast as cells implanted ip, Moreover, this loss continues at an almost constant rate until most of the radioactivity is excreted, giving no evidence of loss by more than one mechanism. Therefore, we believe, this continuous excretion of radioactivity from leukemic mice indicates that a corresponding fraction of the labeled tumor population dies each day.
The death of tumor cells could be due to chemical effects resulting from the administration of the thymidine analogue iododeoxyuridine. 1UDR may produce functional changes in the DNA by replacing part of the thymine component with iodouracil. However, except for the gradual increase in radiosensitivity that is observed when I % or more of the thymine has been replaced (19) (20) (21) , the chemical effects of incorporated lUDR appear to be minimal. Since the IUDR used in these studies was prepared without the addition of carrier iodide, its specific activity could be as high as 1 cl,umole, and thymidine substitution by IUDR should therefore be less than one part in 10,000. Consequently, chemical alterations of the tumor cell DNA must be insignificant. Other chemical effects on cell metabolism also appear unlikely because of the extreme dilution of 1UDR and, in any event, these should have disappeared by the time of transplantation.
Radiation effects from the incorporated 125IUDR may also affect the viability of the labeled tumor cells. While much of the radiant energy of 125 1 is emitted as '}'-rays and X rays, which largely escape not only the tumor but also the mouse, there is an important component of electron irradiation from the K-capture process which produces electrons with energies ranging from 34-3 kev and less (22) . The electrons most frequently ejected in 125 1 disintegration have energies in the 3-4 kev range. These electrons largely expend their energy in the nucleus of the cell in which they originate. The more energetic electrons with energies between 22 and 34 kev usually escape the nucleus before they have lost half of their energy (range of 22 kev electrons in water is 8 ,u). From the reported frequency of electrons within the various kev ranges (22) , it can be calculated that the average radiation dose to the cell nucleus is about 8 kev per disintegration of 1251. This compares to a 6 kev irradiation from each tritium disintegration (d). From Marin and Bender's dose-survival curves for cultures of Chinese hamster cells exposed to tritiated thymidine (23) , it can be estimated that one-half to three-quarter dJmin of intranuclear tritium was required to produce measurable cell death (20% loss in clone formation On the other hand the difference in radiosensitivity may be larger than indicated, because some L1210 cells which do not release their 125 1 activity may still be incapable of meeting Marin and Bender's criterion of reproductive potential. Furthermore, our experimental design minimizes the effects of 125 1 toxicity on our results, since the labeled cells are permitted to grow for 2 days in the primary host before being transferred to secondary mice. This period allows time both for the removal of cells damaged by the injection of 1251UDR and the dilution of the radioactivity among the surviving progeny. In any case, the differences in radiosensitivity between Marin and Bender's work and our studies are small enough so that we feel strongly that radiation effects are being observed at the higher doses of 1251UDR. Such adverse effects of 125 1 irradiation on the viability of transplanted tumor cells can be avoided by use of sufficiently low doses of 1251.
In the case of Ll210 cells labeled ip with 125 1, a dose of less than 5 JLC per mouse seems satisfactory. This should keep the level of incorporation below 0.03 JLC per million tumor cells. We feel that safe dosage limits should be determined for each cell line studied and therefore would caution that our results for Ehrlich cells may include radiation VOL. 43, NO. 4, OCTOBER 1969 effects, although 4 days were allowed to intervene between labeling and transplantation.
Mice inoculated with heat-killed labeled Ll210 cells excrete about 90% of the 125 1 activity within 2 days after implantation. When dead labeled tumor cells are added to unlabeled peritoneal Ll210 populations at various stages of tumor development, the 125 1 activity is also rapidly excreted (11) . These observations indicate that only a small proportion of the radioactivity released from the dead tumor cells is reutilized. The high rate of 125 1 excretion from dead tumor cells and the relatively inefficient reutilization of radioactive DNA breakdown products in new DNA synthesis combine to make the 1251UDR technique a sensitive method for monitoring nonlogarithmic rates of tumor cell death in vivo, i.e., in the range of up to 95% cell death.
Since the radioactivity of dead tumor cells is not completely and instantaneously excreted from the leukemic mice, various steps involved in the breakdown of dead tumor cells have to be considered before the rate of 125 1 excretion can be taken as a quantitative index of tumor cell death. The excretion of radioactivity from mice inoculated with dead tumor cells, or with radioactive nucleoprotein, is much slower than from mice given injections of radioiodide. This indicates that iodide excretion per se is not the limiting factor in our experiments, but that the rates of autolysis or phagocytosis and of DNA breakdown are the significant factors affecting the shape of the curves after inoculation of inviable cells. Autolysis does not appear to be a major rate-controlling factor, since there is no significant difference in 125 1 excretion between mice inoculated with heat-, frceze-, or irradiation-killed tumor cells. The rate of phagocytosis should depend on the location of the dead cells within the body. This may explain the extremely slow excretion of radioactivity from dead cells injected sc. Phagocytosis may also be a limiting factor in other injection sites. Reutilization of the label, although less important, also slows the 125 1 excretion. This effect becomes most pronounced between 2 and 4 days after the inoculation of dead cells, when most of the catabolic radioactivity has been excreted while the epithelial cells still retain a large fraction of the reutilized label (table 1) . Retention of 125 1 in the skin (urinary contamination) is another factor slowing the excretion of radioactivity from mice inoculated with dead labeled tumor cells (table 1) .
Factors affecting cell death.-Following ip or im inoculation, the fractional rate of 125 1 loss obtained with living inocula is much smaller than the rate observed with dead cells. This indicates that the rate of 125 1 excretion from mice bearing living labeled tumor cells is not limited by the rate of breakdown of dead cells, but by the rate of tumor cell death. Retention of radioactivity due to reutilization and urinary contamination is also not a major factor in mice inoculated with living labeled tumor cells (table 1) . Most of the 125 1 activity remaining in such mice is associated with the DNA of the tumor cells, and the relatively small fraction retained elsewhere in the mouse does not significantly affect the initial slope of the 125 1 excretion curve. The rate and amount of 125 1 loss thus provide minimal estimates of cell death. This would appear to closely approach the actual rate of tumor cell death in vivo for ip or im administered cells.
Quantitative estimates for iv administration are less precise, since the cell death rate is so high that rates of catabolism and excretion may need to be considered, and these are not yet available for iv administered dead cells. After sc administration, counts on living mice are meaningless because the excretion rate was the same for living and dead inocula.
Continuous fractional death is not a peculiarity of the L1210 lymphoma. Ehrlich ascites cells (text- fig. 4 ) and WR-6 lymphocytic rat leukemia cells (unpublished observations) also show a high rate of cell death throughout the development of the tumor. Continuous in vivo death of tumor cells may therefore be characteristic of many transplantable tumor lines. The reasons for the high rate of cell death in logarithmically growing populations of tumor cells are not apparent. It may be that in each generation a certain percentage of daughter cells are nonviable as a result of mitotic alterations, which are frequently observed in neoplastic tissues (25) . However, amethopterin, which slows the generation time of L1210 cells, does not decrease the death rate as might be expected from this hypothesis (26) . Furthermore, reproductive cell death does not explain the different rates of cell death observed after different routes of inoculation. Therefore, local environmental factors within the host must play an important role in causing the death of tumor cells.
Since the cell death begins too early after transplantation to result from a conventional immune response of the host, other types of host-tumor interactions must be involved. Cell death appears to be slowest in the peritoneal cavity and more rapid in other parts of the body (cJ. death rates after ip inoculation vs, other inoculation routes). We believe that the high rate of cell death after iv inoculation of Ll210 cells is caused by mechanical stress on the tumor cells in the bloodstream. Inadequate nutrition due to lack of vascularization may also playa role, especially after sc inoculation. However, other mechanisms cannot be excluded, although they are still poorly understood. Electron microscopic studies on the invasion of skeletal and smooth muscle fibers by Ll210 cells have shown that many leukemic cells growing in these organs undergo various degenerative changes (27) . Partial or complete disappearance of the plasma membranes occurred in many leukemia cells, especially in those located in the host-tumor interzone. Aggregates of ribosomes and other cytoplasmic components, derived from the disintegrating leukemia cells, were frequently detected in the interstitial spaces between leukemic cells and muscle. The presence of this material initially seemed to exert a stimulatory effect on the muscle fibers (hyperplasia of cell organelles), but eventually caused the degradation and lysis of the normal structures. These observations suggest that tumor cell death may be a factor in the destruction of normal tissues in the course of tumor invasion. The death of tumor cells could therefore be the result of a host-tumor interaction. The absence of such a mechanism in the peritoneal cavity would account for the much smaller death rate of the peritoneal tumor cells.
Cell migration.-Besides offering a useful tool for monitoring the rate of tumor cell death throughout the development of the tumor, the 125IUDR_ prelabeling technique makes it possible to quantitatively study the migration and metastatic spread of tumor cells. In most organs the amount of radioactivity can be taken as an index of tumor cell migration if proper corrections are made for reutilization and for residual catabolic radioiodide. For instance, the skin and the intestine retain as much radioactivity in mice inoculated with dead labeled tumor cells as in mice receiving living inocula (table 1) , and, therefore, the data provide no evidence of metastasis to these organs. While the skin may contain some metastatic cells, it also contains large and variable amounts of excreted radioactivity that is difficult to remove. Therefore, this organ was not analyzed further. Since cell renewal in the intestine normally accounts for almost half of the DNA synthesis in the mouse (12) , most of the activity in the intestine can be readily attributed to radioactive IUDR released from dead labeled tumor cells and reutilized by the rapidly proliferating cells of the intestinal epithelium. Similarly, an appreciable fraction of the activity in the spleen must result from reutilization. These artifacts could be eliminated and more detailed information obtained by autoradiographic analysis, which could differentiate weakly labeled cells (reutilization) from those of the original inoculum. Most of the radioactivity in the liver seems to be attributable to metastatic tumor cells, and since the amount of 125 1 in this organ depends on the route of implantation, some information as to the mechanisms of tumor migration can be obtained.
The factors responsible for the metastatic spread of tumor cells are complex. The formation of metastases in distant parts of the body depends on the ability of the tumor cells to invade adjacent normal tissues and gain entrance to the vascular system. Two different concepts have been advanced to explain the distribution of blood-borne metastases. Some investigators believe that purely anatomical or mechanical factors of the blood flow are sufficient to explain the organ distribution of tumor cells (28) , whereas others maintain that various tissues of the body have different metabolic or biologic properties which encourage or inhibit the growth of migrating tumor cells (29) (30) (31) . Recent studies on the behavior of different tumor lines in the same strain of animals indicate that intrinsic factors within the tumor cell itself may also influence the pattern of metastatic spread (10) . In the present studies the differences between Ll210 and the Ehrlich tumor in terms of cell migration are truly impressive. In fact, our data show no evidence of measurable migration of the Ehrlich tumor from the peritoneal cavity. This may explain the longer lifespan of mice carrying this tumor.
With iv injected Ll210 cells, the liver and especially the spleen accumulate 125 1 activity disproportionate to their contribution to the body mass (table 1) . If the tumor cells were distributed uniformly throughout the body of the mouse, the liver should retain no more than 10% and the spleen less than 1% of the radioactivity present at the time the animals are killed. Actually, the liver contains up to 50% and the spleen almost 7% of the radioactivity associated with tumor cells 4 days after iv inoculation (the 125 1 content of skin and intestine are disregarded in this calculation because their radioactivity does not represent tumor cells). Ll210 cells inoculated im also migrate selectively, though in smaller numbers to the liver (20%) and spleen (5%) (the radioactivity remaining at the site of inoculation, the leg muscles, is not included in this calculation). A similar situation exists when Ll210 cells are implanted sc. The data for ip inoculation do not indicate preferential accumulation ofLl21O cells in the liver and spleen. However, this is probably because the values given in table 1 for the "rest of the body" are not corrected for local metastases of tumor cells within the peritoneal cavity. Our results, therefore, indicate that the anatomical distribution of Ll210 cells which have migrated from the site of inoculation is determined primarily by the organ factor (preferential accumulation of Ll210 cells in liver and spleen), although the route of inoculation and therefore the transport factor also influence the pattern of tumor spread.
CONCLUSIONS
The technique of 125IUDRlabeling of tumor cells permits a quantitative study of tumor cell migration and tumor cell death in vivo. Care must be taken to avoid damaging cells by the labeling procedure or by radiation from excessive amounts of incorporated radioisotopes. The procedure is most valuable in determining early cell death during logarithmic growth of the tumor and has already been used to distinguish between cytocidal and cytostatic effects of antimetabolites (26, 32) . It becomes insensitive when most of the labeled cellshave died since, under these circumstances, variations in the residual load remaining from earlier cell death destroy the precision of measurement. The site of implantation also affects the precision of the results, and sc implantation has proved unsuccessful, since mice inoculated subcutaneously lose radioactivity at the same rate whether the cells are living or dead. Recent reports have also appeared in which IUDR is used in studies on cell death in solid tumors (33) (34) (35) .
